Abstract
BackgroundTo date, the five anti-TNFα biologics on the market are firmly established as therapeutics across several inflammatory and autoimmune disorders including rheumatoid arthritis (RA), inflammatory bowel diseases (IBD), psoriatic arthritis,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have